Supplementary Legend from First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors

Authors :: David M. Hyman
Christopher M. Haqq
Willis H. Navarro
Drew W. Rasco
Joyce F. Liu
Karen A. Cadoo
Vicky Makker
Nicholas A. Cangemi
Jessica J. Tao
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Legend

Full Text Access

Tools